Both in Pharmaceuticals

CervoMed vs Seres Therapeutics

Over the past year CRVO returned −77.8% and MCRB returned −84.8%; their daily moves had a correlation of 0.13.

CRVO −77.8% MCRB −84.8%Growth of $1, one year, split-adjusted
MetricCRVOMCRB
Price$1.56$2.09
Market cap$23.6M$21.0M
Today+0.65%+6.63%
1 month−53.3%−27.9%
6 months−59.3%−73.9%
Year to date−80.3%−86.0%
1 year−77.8%−86.3%
Revenue growth (YoY)−100.0%—
Gross margin—100.0%
Net margin—622.4%
P/E (TTM)——
Price / sales71.2×11.1×
Net cash$24.9M$15.6M
Dividend yield——
Volatility (60d)88.5%73.3%
Short % of float12.7%4.4%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).

CRVO vs MCRB: CervoMed vs Seres Therapeutics Stock Comparison | Gainbot